Search

  • Home
  • News
    • GenomeWeb Daily News
    • BioArray News
    • BioInform
    • In Sequence
    • PCR Insider
    • PGx Reporter
    • ProteoMonitor
    • RNAi News
  • Magazine
  • Blog
    • The Daily Scan
    • Informatics Iron
    • The Sample
  • Careers
    • Job Listings

Log in or Register
Tuesday, March 16, 2010
  • Arrays
  • Bioregionnews
  • Biotechtransferweek
  • Cbanews
  • DxPGx
  • Informatics
  • PCR/Sample Prep
  • Proteomics
  • RNAi
  • Sequencing
Home » News » Pharmacogenomics Reporter

New Releases

July 08, 2009
  • Type size: - +
  • Email
  • Printer-friendly version
  • RSS Feed

Exiqon's BRAF mutation analysis

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.

Related Stories

  • Q&A: Mohammad Ilyas on PCR, High-Res Melting to Detect DNA Mutations in FFPE Tissue
    February 24, 2010 / PCR Insider
  • Amgen Lays Out Timeline for KRAS Mutation Studies to Dispel Perceptions of Unethical Rx Development
    February 24, 2010 / Pharmacogenomics Reporter
  • Roche Charges DxS of Ditching Distribution Agreement in Favor of Parent Qiagen
    February 24, 2010 / Pharmacogenomics Reporter
  • Transgenomic Launches Surveyor KRAS Mutation Test Kit; Touts Advantages Over Rival Platform
    December 9, 2009 / Pharmacogenomics Reporter
  • Qiagen Acquires UK's DxS in Deal Worth up to $130M
    September 23, 2009 / GenomeWeb Daily News

In this issue of Pharmacogenomics Reporter

  • PGx Advocates View Federal Comparative Effectiveness Report as Boost for Personalized Healthcare
  • GPPC's Plan for Mandatory Genetic Test Registry Includes All Health-related Diagnostics
  • St. Gallen's Recommendations May Impact Adoption of Leading Breast Cancer Genetic Tests
  • Coriell Informs Handful of Participants of Delays in Risk Results Due to Faulty Reagent
  • Young Investigator Profile

    Christopher Maher

    University of Michigan Medical School
    Research Investigator

    Gene Fusions and Transcriptome Sequencing

    Christopher Maher is focused on elucidating gene fusions, which he first became acquainted with during his potdoctoral work at the Michigan Center for Translational Pathology. Maher hopes to continue discovering novel gene fusions as well as draw new findings out of already-known gene fusions. Last year, he published a paper in Nature in January of 2009 entitled "Transcriptome sequencing to detect gene fusions in cancer," which he says provides a validation for the approach of using next-gen sequencing to find gene fusions in cancer. This was followed up by a PNAS paper in July which demonstrated the gene fusion concept using paired-end transcriptome sequencing.

  • Blog

    New Choice for NSF

    MIT's Subra Suresh may be the next director of the National Science Foundation.

    March 16, 2010

    Running Around the CDC

    The New York Times profiles Thomas Frieden, the director of the CDC.

    March 16, 2010

    Large Medco-Mayo Clinic Study Could Drive Genetic Testing for Warfarin Dosing

    The large prospective study found that hospitalization rates for heart patients taking the blood thinner fell by nearly one-third "when genetic information was available to doctors prescribing the drug."

    March 16, 2010

    But Does It Come with a Corkscrew and Tweezers?

    Researchers at HHMI are unveiling a new software package for analyzing complex biological images in 3D.

    March 16, 2010
  • Papers of Note

    Regulation and Function of miR-218 in Gastric Cancer Metastasis
    Tie, Pan et al., PLoS Genetics
    Researchers describe a negative feedback system between Robo1, a Slit receptor, and miR-218, wherein “decreased miR-218 levels eliminate Robo1 repression, which activates the Slit-Robo1 pathway through the interaction between Robo1 and Slit2, thus triggering tumor metastasis.” The authors suggest that the restoration of miR-218 supresses Robo1 espression and inhibits tumor cell invasion.

    Method to Label and Isolate N-terminal Peptides from Human Plasma
    Wildes and Wells, PNAS
    A pair of researchers report their method to “dramatically reduce the complexity” of human serum samples by eliminating internal peptides. The authors write that, with their method, it's possible to identify substrates from specific proteases with the exogenous addition of the protease along with N-terminal isolation and quantitative mass spectrometry.

  • People on the Move

    Wellcome Trust Sanger Institute Professor Leena Peltonen-Palotie died this week of cancer at her home in Finland, according to the Sanger Institute. Peltonen-Palotie was head of human genetics at Wellcome Trust, and she held appointments at the Broad Institute at MIT and Harvard and the Institute for Molecular Medicine Finland.


    Three leaders from the Human Genome Project — David Botstein, Francis Collins, and Eric Lander — have been named co-winners of the 2010 Albany Medical Center Prize in Medicine and Biomedical Research, which carries with it a purse of $500,000.


    Adrian Dillon will resign from his job as executive VP of finance and administration and CFO of Agilent Technologies to become chief financial and administrative officer at Skype. He will be replaced at the beginning of April by Didier Hirsch, who currently is VP of corporate controllership and taxes and who will serve as acting CFO.

  • Upcoming Events

    Conferences, Meetings & Deadlines

    PTEN Pathways & Targets
    Mar. 16-20 / Cold Spring Harbor, NY
    CSHL

    The Complex Life of mRNA: From Synthesis to Decay
    Mar. 18-19 / Heidelberg, Germany
    EMBL

    Perspectives in Clinical Proteomics
    Mar. 18-19 / Hinxton, UK
    EMBL-EBI-Wellcome Trust

    AUTM 2010 Annual Meeting
    Mar. 18-20 / New Orleans, La.
    Association of University Technology Managers

    ABRF 2010
    Mar. 20-23 / Sacramento, CA
    Association of Biomolecular Resource Facilities

    Abstract & Registration Deadlines
    more
  • Science

    Researchers from the Institute for Systems Biology and elsewhere used Complete Genomics' sequencing service to identify mutations behind a Mendelian condition called Miller syndrome and an inherited lung disorder called ciliary dyskinesia in a family of four.
  • Business

    Bruker will acquire certain mass spectrometry and chromatography product lines from Varian, clearing the way for Agilent to complete its $1.5 billion acquisition of Varian. The divestitures were part of conditions set by EU authorities for approval of the merger.
  • Funding

    HHS expects that in 2010 NIH will spend another roughly $5.2 billion overall in stimulus funds that were left over from ARRA's first year. NIH still has more than $1.6 billion to spend in stimulus funds for lab construction and renovation, buildings and facilities, and shared instruments.
  • Genome Technology Magazine

    Check out this month's humor page here:
    blunt end

TechGuides Listings

  • Genetic Variation
  • Tech Guide Archives

Poll

Powered by Drupal, an open source content management system
Copyright © 2010 Genomeweb LLC. All rights reserved. About | FAQ | Subscriptions | Contact us